NO940788D0 - Benzoxazin-derivater, deres fremstilling og deres terapeutiske anvendelse - Google Patents

Benzoxazin-derivater, deres fremstilling og deres terapeutiske anvendelse

Info

Publication number
NO940788D0
NO940788D0 NO940788A NO940788A NO940788D0 NO 940788 D0 NO940788 D0 NO 940788D0 NO 940788 A NO940788 A NO 940788A NO 940788 A NO940788 A NO 940788A NO 940788 D0 NO940788 D0 NO 940788D0
Authority
NO
Norway
Prior art keywords
group
tetrahydroisoquinol
methoxy
phenyl
dimethoxy
Prior art date
Application number
NO940788A
Other languages
English (en)
Other versions
NO940788L (no
NO300542B1 (no
Inventor
Paul Howard Williams
Lydia Zard
Thomas Andrew Purcell
Daniel Galtier
Jean-Claude Muller
Pascal George
Jonathan Frost
Patrick Pasau
Corinne Rousselle
Regine Bartsch
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO940788D0 publication Critical patent/NO940788D0/no
Publication of NO940788L publication Critical patent/NO940788L/no
Publication of NO300542B1 publication Critical patent/NO300542B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO940788A 1993-03-08 1994-03-07 Benzoksazinforbindelser og medikament inneholdende slike NO300542B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9302659A FR2702477B1 (fr) 1993-03-08 1993-03-08 Dérivés de benzoxazine, leur préparation et leur application en thérapeutique.

Publications (3)

Publication Number Publication Date
NO940788D0 true NO940788D0 (no) 1994-03-07
NO940788L NO940788L (no) 1994-09-09
NO300542B1 NO300542B1 (no) 1997-06-16

Family

ID=9444751

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940788A NO300542B1 (no) 1993-03-08 1994-03-07 Benzoksazinforbindelser og medikament inneholdende slike

Country Status (20)

Country Link
US (1) US5447928A (no)
EP (1) EP0614893B1 (no)
JP (1) JPH0710852A (no)
CN (1) CN1099032A (no)
AT (1) ATE166648T1 (no)
AU (1) AU673226B2 (no)
CA (1) CA2117122A1 (no)
CZ (1) CZ284789B6 (no)
DE (1) DE69410509T2 (no)
DK (1) DK0614893T3 (no)
ES (1) ES2119099T3 (no)
FI (1) FI941068A (no)
FR (1) FR2702477B1 (no)
HU (1) HUT70539A (no)
IL (1) IL108885A (no)
NO (1) NO300542B1 (no)
NZ (1) NZ260039A (no)
RU (1) RU2130020C1 (no)
SK (1) SK27494A3 (no)
TW (1) TW302362B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1109880A (zh) * 1994-02-03 1995-10-11 合成实验室公司 3-(2-氨基乙基)-4-[3-(三氟甲基)苯甲酰基]-3,4-二氢-2h-1,4-苯并噁嗪衍生物、制备及其应用
US6339087B1 (en) 1997-08-18 2002-01-15 Syntex (U.S.A.) Llc Cyclic amine derivatives-CCR-3 receptor antagonists
IL125658A0 (en) 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
WO1999038500A2 (en) * 1998-01-30 1999-08-05 The Brigham And Women's Hospital, Inc. The human calcium-sensing receptor in the detection and treatment of cancer
TW472491B (en) * 1999-03-19 2002-01-11 Seiko Epson Corp Projection system and projector
US6391907B1 (en) 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
US6355648B1 (en) 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
UA73119C2 (en) 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
AU2005292314B2 (en) * 2004-09-29 2011-11-03 Portola Pharmaceuticals, Inc. Substituted 2H-1,3-benzoxazin-4(3H)-ones
AR051780A1 (es) * 2004-11-29 2007-02-07 Japan Tobacco Inc Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos
HU230826B1 (hu) 2014-11-19 2018-07-30 Richter Gedeon Nyrt. Eljárás benzazepin származékok előállítására

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1287584B (de) * 1962-07-04 1969-01-23 Thomae Gmbh Dr K Verfahren zur Herstellung von 2, 3-Dihydro-1, 4-benzoxazinderivaten
GB8803419D0 (en) * 1988-02-15 1988-03-16 Erba Carlo Spa 1 4-benzoxazine & 1 4-benzothiazine derivatives & process for their preparation
AU638154B2 (en) * 1990-10-04 1993-06-17 Suntory Limited Benzoxazine derivative and herbicide containing same as an active ingredient
DE4037427A1 (de) * 1990-11-24 1992-05-27 Kali Chemie Pharma Gmbh Heterocyclisch substituierte piperazinoalkylbenzoxazin und -thiazin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
FR2702477A1 (fr) 1994-09-16
HUT70539A (en) 1995-10-30
FI941068A (fi) 1994-09-09
IL108885A0 (en) 1994-06-24
DE69410509T2 (de) 1999-01-28
CA2117122A1 (en) 1994-09-09
AU5758694A (en) 1994-09-15
EP0614893B1 (fr) 1998-05-27
ES2119099T3 (es) 1998-10-01
ATE166648T1 (de) 1998-06-15
US5447928A (en) 1995-09-05
NZ260039A (en) 1995-06-27
CN1099032A (zh) 1995-02-22
RU2130020C1 (ru) 1999-05-10
DK0614893T3 (da) 1999-03-22
AU673226B2 (en) 1996-10-31
NO940788L (no) 1994-09-09
FI941068A0 (fi) 1994-03-07
FR2702477B1 (fr) 1995-04-28
JPH0710852A (ja) 1995-01-13
CZ284789B6 (cs) 1999-03-17
HU9400671D0 (en) 1994-06-28
DE69410509D1 (de) 1998-07-02
EP0614893A1 (fr) 1994-09-14
NO300542B1 (no) 1997-06-16
CZ51694A3 (en) 1994-10-19
IL108885A (en) 1998-02-22
TW302362B (no) 1997-04-11
SK27494A3 (en) 1995-03-08

Similar Documents

Publication Publication Date Title
NO940788L (no) Benzoxazin-derivater, deres fremstilling og deres terapeutiske anvendelse
FI922983A0 (fi) Pyrimidin-4-karboxamidderivat, framstaellning av dessa och terapeutisk anvaendning av dessa.
FI892344A (fi) 6-fenyl-3-piperazinylalkyl-1h,3h -pyrimidin-2-4-dionderivat, deras framstaellning och deras terapeutiska anvaendning.
ES2083479T3 (es) Bis(hidroximetil)ciclobutil-purinas y pirimidinas fluoradas.
ATE111460T1 (de) 2-(aminoalkyl)-5-(arylalkyl)1,3-dioxanderivate, ihre herstellung und ihre anwendung in der therapeutik.
EP1270569A4 (en) SUBSTITUTED TRYPTOPHAN DERIVATIVES
ATE123025T1 (de) 2-amino-n-(((4-(aminocarbonyl)pyrimidin-2- yl>amino>alkyl>-pyrimidin-4- carbonsäureamidderivate, ihre herstellung und ihre anwendung in der therapeutica.
HUP0002715A2 (hu) Benzotiofénszármazékok alkalmazása trombocitaszám csökkentésére szolgáló gyógyszerkészítmények előállítására
DK0520882T3 (da) Derivater af 2-aminopyrimidin-4-carboxamid, deres fremstilling og deres terapeutiske anvendelse
DK599486A (da) 1,4-dihydropyridiner, deres fremstilling af anvendelse som laegemidler
ATE154010T1 (de) 2-phenyl- und 2-thienyl-(2)-piperidinderivate mit neuroprotektiven eigenschaften
NO941830L (no) Karboksamid-derivater, deres fremstilling og anvendelse som terapeutika
NO932779L (no) Tetrahydronaftalenderivater, fremgangsmaate for deres fremstilling og anvendelse derav